Reporting randomized, controlled trials of herbal interventions: An elaborated CONSORT statement

被引:393
作者
Gagnier, JJ
Boon, H
Rochon, P
Moher, D
Barnes, J
Bombardier, C
机构
[1] Univ Toronto, Toronto, ON, Canada
[2] Inst Evaluat Sci, Toronto, ON, Canada
[3] Inst Work & Hlth, Toronto, ON, Canada
[4] Toronto Gen Res Inst, Toronto, ON, Canada
[5] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada
[6] Univ London, London, England
关键词
D O I
10.7326/0003-4819-144-5-200603070-00013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Herbal medicinal products are widely used, vary greatly in content and quality, and are actively tested in randomized, controlled trials (RCTs). The authors' objective was to develop recommendations for reporting RCTs of herbal medicine interventions, based on the need to elaborate on the 22-item CONSORT (Consolidated Standards of Reporting Trials) checklist. Telephone calls were made and a consensus meeting was held with 16 participants in Toronto, Canada, to develop these recommendations. The group agreed on context-specific elaborations of 9 CONSORT checklist items for RCTs of herbal medicines. Item 4, concerning the herbal medicine intervention, required the most extensive elaboration. These recommendations have been developed to improve the reporting of RCTs using herbal medicine interventions.
引用
收藏
页码:364 / 367
页数:4
相关论文
共 22 条
[11]   Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations [J].
Kressmann, S ;
Biber, A ;
Wonnemann, M ;
Schug, B ;
Blume, HH ;
Müller, WE .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (11) :1507-1514
[12]   Pharmaceutical quality of different Ginkgo biloba brands [J].
Kressmann, S ;
Müller, WE ;
Blume, HH .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (05) :661-669
[13]   Simultaneous determination of terpene lactones and flavonoid aglycones in Ginkgo biloba by high-performance liquid chromatography with evaporative light scattering detection [J].
Li, WK ;
Fitzloff, JF .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 30 (01) :67-75
[14]   The methodological quality of randomized controlled trials of homeopathy, herbal medicines and acupuncture [J].
Linde, K ;
Jonas, WB ;
Melchart, D ;
Willich, S .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2001, 30 (03) :526-531
[15]  
Little C., 2000, COCHRANE LIB, P4
[16]  
Manning Jared, 2003, Journal of Herbal Pharmacotherapy, V3, P19, DOI 10.1080/J157v03n03_03
[17]   The CONSORT statement: Revised recommendations for improving the quality of reports of parallel group randomized trials [J].
Moher D. ;
Schulz K.F. ;
Altman D.G. ;
Lepage L. .
BMC Medical Research Methodology, 1 (1) :1-7
[18]   Assessing the quality of reports of randomized trials in pediatric complementary and alternative medicine [J].
Moher D. ;
Sampson M. ;
Campbell K. ;
Beckner W. ;
Lepage L. ;
Gaboury I. ;
Berman B. .
BMC Pediatrics, 2 (1)
[19]   Variations in parthenolide content and daily dose of feverfew products [J].
Nelson, MH ;
Cobb, SE ;
Shelton, J .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (16) :1527-1531
[20]   Heavy metal content of Ayurvedic herbal medicine products [J].
Saper, RB ;
Kales, SN ;
Paquin, J ;
Burns, MJ ;
Eisenberg, DM ;
Davis, RB ;
Phillips, RS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (23) :2868-2873